Jon Harris

Jon Harris is an experienced professional in regulatory affairs, currently serving as Executive Director of Regulatory Affairs CMC at Exelixis since June 2025. Previously, Jon held senior roles at IGM Biosciences, Inc. and Bolt Biotherapeutics, Inc., specializing in regulatory affairs for CMC. Notable experience includes Associate Vice President at Omeros Corporation, with a focus on developing global regulatory strategies and overseeing regulatory plans, as well as Senior Director at AstraZeneca, managing regulatory strategy for biosimilar therapeutics. Jon’s career also encompasses significant contributions to various companies including Stem CentRx and Genentech, where Jon progressively advanced through regulatory management roles. With a foundation in life sciences research from NASA Ames Research Center and early work in the Cystic Fibrosis Center of New York, Jon's educational background includes a BA in History from the University of California, Berkeley, and advanced studies at the University of California, San Francisco.